Rice's Biotech Launch Pad to lead commercialization of bioelectrical implant treatment for obesity, type 2 diabetes
October 02, 2024
October 02, 2024
HOUSTON, Texas, Oct. 2 -- Rice University issued the following news release:
Rice University is part of a multiuniversity research team that has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of a bioelectronic implant designed to improve adherence for obesity and type 2 diabetes (T2D) treatment while reducing development and manufacturing costs.
Omid Veiseh is a professor of bioengin . . .
Rice University is part of a multiuniversity research team that has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of a bioelectronic implant designed to improve adherence for obesity and type 2 diabetes (T2D) treatment while reducing development and manufacturing costs.
Omid Veiseh is a professor of bioengin . . .